Related Experiment Video
Updated: May 12, 2026
Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from
Yang-Yang Tian1,2, Jian-Bo Tong3, Yuan Liu3
1College of Petroleum Engineering, Xi'an Shiyou University, Xi'an 710065, China.
Abstract:
Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA methods are used to establish models of 65 imidazo[4,5-b]pyridine derivatives to explore the quantitative structure-activity relationship between their anticancer activities and molecular conformations. The results show that the cross-validation coefficients q2 of HQSAR, CoMFA, CoMSIA and TopomerCoMFA are 0.892, 0.866, 0.877 and 0.905, respectively. The non-cross-validation coefficients r2 are 0.948, 0.983, 0.995 and 0.971, respectively. The externally validated complex correlation coefficients r2 of external validation are 0.814, 0.829, 0.758 and 0.855, respectively. The PLS analysis verifies that the QSAR models have the highest prediction ability and stability. Based on these statistics, virtual screening based on R group is performed using the ZINC database by the Topomer search technology. Finally, 10 new compounds with higher activity are designed with the screened new fragments. In order to explore the binding modes and targets between ligands and protein receptors, these newly designed compounds are conjugated with macromolecular protein (PDB ID: 1MQ4) by molecular docking technology. Furthermore, to study the nature of the newly designed compound in dynamic states and the stability of the protein-ligand complex, molecular dynamics simulation is carried out for N3, N4, N5 and N7 docked with 1MQ4 protease structure for 50 ns. A free energy landscape is computed to search for the most stable conformation. These results prove the efficient and stability of the newly designed compounds. Finally, ADMET is used to predict the pharmacology and toxicity of the 10 designed drug molecules.
Insights
This study develops quantitative structure-activity relationship (QSAR) models for anticancer imidazo[4,5-b]pyridine derivatives. New compounds were designed, docked, and simulated, showing promising anticancer potential and stability.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Cancer poses a significant global health challenge, necessitating advanced scientific strategies for prevention and control.
- Understanding the relationship between molecular structure and biological activity is crucial for designing effective anticancer agents.
Purpose of the Study:
- To establish robust quantitative structure-activity relationship (QSAR) models for imidazo[4,5-b]pyridine derivatives with anticancer activity.
- To design novel, potent anticancer compounds through virtual screening and molecular design.
- To evaluate the binding interactions, stability, and pharmacokinetic properties of the designed compounds.
Main Methods:
- Quantitative Structure-Activity Relationship (QSAR) modeling using HQSAR, CoMFA, CoMSIA, and TopomerCoMFA.
- Virtual screening via Topomer search technology on the ZINC database.
- Molecular docking and molecular dynamics (MD) simulations with the 1MQ4 protein target.
- ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction.
Main Results:
- Highly predictive QSAR models were developed with excellent cross-validation (q²) and non-cross-validation (r²) coefficients.
- Virtual screening identified promising fragments, leading to the design of 10 novel compounds with enhanced predicted anticancer activity.
- Molecular docking and 50 ns MD simulations demonstrated stable binding interactions and favorable conformational landscapes for the designed compounds.
- ADMET predictions indicated favorable pharmacokinetic profiles and low toxicity for the novel drug candidates.
Conclusions:
- The established QSAR models effectively predict the anticancer activity of imidazo[4,5-b]pyridine derivatives.
- The designed novel compounds exhibit significant potential as anticancer agents due to their predicted efficacy and stability.
- This integrated computational approach provides a reliable strategy for accelerating the discovery of new anticancer therapeutics.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
01:30Enzyme Inhibition
02:18The Equilibrium Binding Constant and Binding Strength
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:16Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...